再鼎医药(09688.HK)获摩根大通增持615.01万股

Group 1 - JPMorgan Chase & Co. increased its stake in Zai Lab Limited (09688.HK) by purchasing 6.1501 million shares at an average price of HKD 14.6037 per share, totaling approximately HKD 89.8144 million [1] - Following the acquisition, JPMorgan's total holdings in Zai Lab rose to 59.5266 million shares, increasing its ownership percentage from 4.76% to 5.31% [1]